Takeda In Neuroscience
Our focus in neuroscience is driven by the unmet need of patients with neurologic diseases, mental health and psychiatric disorders. Our mission is to bring innovative and potentially disease-modifying medicines to these individuals.
Our dedication extends beyond our marketed products and research efforts. We are committed to raising awareness for these conditions, building strategic partnerships with both industry and advocacy, educating patients and physicians, and broadening access to therapies.
Takeda’s world-class R&D team has an unwavering commitment and passion for developing innovative therapies. We collaborate in areas where patients’ needs are greatest, forming partnerships that will enable us to make a greater impact on patients’ lives - now and in the future. Together with researchers, patient groups and more, Takeda is working to advance scientific research and clinical medicine and will continue our search for better disease management for all those affected by CNS diseases and neurological conditions.
Attention Deficit Hyperactivity Disorder
ADHD is a common neurodevelopmental disorder affecting people of all ages.1
Binge Eating Disorder
Binge eating disorder is a serious mental health disorder characterised by frequently eating large amounts of food and losing control of eating.2,3
TAKEDA: MAKING A DIFFERENCE, PROVIDING TRULY PATIENT-CENTRIC CARE
At Takeda, we believe in order to make a difference and provide truly patient-centric care, it is important to understand patient and healthcare professional’s needs and go one step further. We believe in supporting the needs of healthcare professionals and patients alike, with the right support and resources which are now easier than ever to access via TakedaPro.
Have you registered?
resources, services & expert knowledge.
- Australian Evidence-Based Clinical Practice Guideline For Attention Deficit Hyperactivity Disorder (ADHD) - https://adhdguideline.aadpa.com.au/
- American Psychiatric Association. Binge-eating disorder. In: Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013:350-353.